Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer (ProVent)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03686683 |
|
Recruitment Status :
Active, not recruiting
First Posted : September 27, 2018
Last Update Posted : May 20, 2020
|
Sponsor:
Dendreon
Collaborator:
PRA Health Sciences
Information provided by (Responsible Party):
Dendreon
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2023 |
| Estimated Study Completion Date : | May 2023 |